Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
If youre seeking weight loss without diabetes, tirzepatide (Zepbound) is most often the appropriate option to discuss
This triple agonist design, developed by Eli Lilly under the research code LY3437943, represents a fundamentally different approach from semaglutide (which targets only GLP-1) or tirzepatide (which targets GLP-1 and GIP)
Semaglutide, the active ingredient in Ozempic and Wegovy, and tirzepatide, the active ingredient in Mounjaro and Zepbound, have shifted this paradigm
Price matters, but context matters more
Hunaiti AA et al
US$ 22.66
US$ 26.21
US$ 23.67
US$ 26.03
US$ 22.68
